The Global U.S. Elastomeric Infusion Pumps Market Growth Accelerated By Expansion Of Product Portfolio
![]() |
| U.S. Elastomeric Infusion Pumps Market |
Elastomeric infusion pumps are an essential medical device used for continuous subcutaneous drug delivery such as antibiotics, analgesics, chemotherapy drugs etc. These pump deliver medication slowly and steadily to patients through pre-filled elastomeric bags. Their small size, portability and compatibility with subcutaneous administration makes them a convenient alternative to traditional intravenous delivery systems.
The global U.S. Elastomeric
Infusion Pumps Market is estimated to be valued at US$ 332.46 Bn in 2023 and is
expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2031, as highlighted in a new report
published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the U.S. Elastomeric Infusion Pumps
Market is the expansion of product portfolio by market players. Major players
are focusing on developing advanced elastomeric pumps with improved features to
gain competitive edge. For instance, in 2021, Baxter International Inc.
launched the Elastomeric Ambulatory Infusion Pump system, a next generation
elastomeric pump designed for continuous subcutaneous insulin infusion. The
pump is equipped with reusable drivers and disposable bags which offers 30 days
of insulin delivery. Similarly, in 2022, iceteca GmbH launched an advanced
elastomeric pump platform - icypump, indicated for subcutaneous administration
of drugs. The icypump system combines flexible dosing with mobile connectivity
features. Such product innovations are expected to boost the adoption of
elastomeric pumps, thereby accelerating the market growth over the forecast
period.
Segment Analysis
The U.S. elastomeric infusion pumps market is dominated by large volume
segment. These pumps are suitable for administration of large volume fluids
like antibiotics, chemotherapy drugs, total parenteral nutrition and
analgesics. They offer advantages like precision in delivery of fluids at
pre-set, constant flow rates over extended periods ranging from 24 to 72 hours
without needing to refill during treatment. This makes them suitable for long
term medication delivery leading to their widespread adoption in hospitals and
home healthcare sector.
Key Takeaways
The global U.S.
Elastomeric Infusion Pumps Market Demand is expected to witness high
growth. The global U.S. Elastomeric Infusion Pumps Market is estimated to be
valued at US$ 332.46 Bn in 2023 and is
expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2031.
The Western region currently
dominates the U.S. elastomeric infusion pumps market owing to advanced
healthcare infrastructure and higher adoption of ambulatory elastomeric
infusion pumps in home care settings. The region is expected to continue its
dominance during the forecast period supported by growing geriatric population,
increasing prevalence of chronic diseases and rising healthcare spending.
Key players operating in the
U.S. Elastomeric Infusion Pumps market are Mitsubishi Heavy Industri, Becton,
Dickinson and Company, Baxter International Inc., Braun Melsungen AG, Smiths
Medical, Pfizer Inc., Fresenius Kabi, Medtronic plc, Johnson & Johnson, F.
Hoffmann-La Roche Ltd.
Mitsubishi Heavy Industries focuses on expanding its market share through
partnerships, acquisition and geographic expansion. Baxter International
pursuesorganic as well as inorganic growth strategies to strengthen its market
position.
Check below
related articles on this topic: https://www.newsanalyticspro.com/the-u-s-elastomeric-infusion-pumps-market-analysis/
https://blogger-veritas.blogspot.com/2024/01/the-global-ventricular-assist-devices.html

Comments
Post a Comment